PharmaEngine Announces Taiwan FDA Approval of ONIVYDE (TM) (irinotecan liposome injection) for the Treatment of Metastatic Pancreatic Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/21/2026

1. INTC
2. DSX
3. GNK
4. III
5. TTEC
6. DAL
7. AWK
8. SPCX
9. AMIX
10. Z

Go back to PharmaEngine Announces Taiwan FDA Approval of ONIVYDE (TM) (irinotecan liposome injection) for the Treatment of Metastatic Pancreatic Cancer
(NYSE: BXLT) Delayed: 46.02 --0 (-0%)
Previous Close $46.02    52 Week High $46.52 
Open $16.43    52 Week Low $29.83 
Day High $46.02    P/E N/A 
Day Low $46.02    EPS $0.00 
Volume 72,381       

MERRIMACK PHARM (NASDAQ: MACK) Delayed: 15.13 --0 (-0%)
Previous Close $15.13    52 Week High $9.63 
Open $0.00    52 Week Low $4.39 
Day High $15.13    P/E N/A 
Day Low $15.13    EPS $-1.24 
Volume 3,325,453